Open CFD account Free Demo
Call: +248 4 671 903 Mail: [email protected]
Log In Open Account
Log In Open Account
Log In Open Account
News & Analysis
Open Account
News & Analysis
Open Account

Stop the jab – Johnson & Johnson vaccine rollout paused

14 April 2021 By Klavs Valters

Share

805,734,252 – that’s how many doses of the COVID-19 vaccine have been given globally so far as of the 12th April (from 185 locations), according to Our World in Data. Israel, Bahrain and Chile are leading the way with 54.7%, 24.7% and 24.6% of the population fully vaccinated.

With more and more people getting the jab across the world, the chance of side effects becomes more likely. We have already seen the AstraZeneca vaccine being suspended for use for in few countries. Today, it was announced that the US agencies are calling to pause the Johnson & Johnson vaccine rollout after reports of extremely rare blood clot cases.

Following the FDA and CDC advice, all federal sites in the US have stopped using the vaccine until further investigation.

European Union and South Africa have also confirmed that they will temporally stop the rollout of the Johnson & Johnson jab.

The share price of Johnson & Johnson was down by around 1.34% following the latest news on their vaccine, trading at $159.48 per share the close. The stock is up by 1.57% year-to-date.

Johnson & Johnson – YTD Chart

Source: TradingView

You can trade Johnson & Johnson (JNJ) and many other stocks from the ASX, NYSE, and the NASDAQ with GO Markets as a Share CFD. Click here for more information. Trading Derivatives carries a high level of risk.

The information provided is of general nature only and does not take into account your personal objectives, financial situations or needs. Before acting on any information provided, you should consider whether the information is suitable for you and your personal circumstances and if necessary, seek appropriate professional advice. All opinions, conclusions, forecasts or recommendations are reasonably held at the time of compilation but are subject to change without notice. Past performance is not an indication of future performance. Go Markets Pty Ltd, ABN 85 081 864 039, AFSL 254963 is a CFD issuer, and trading carries significant risks and is not suitable for everyone. You do not own or have any interest in the rights to the underlying assets. You should consider the appropriateness by reviewing our TMD, FSG, PDS and other CFD legal documents to ensure you understand the risks before you invest in CFDs. These documents are available here.

#Indice #Indices #IndicesTrading #IndexTrading #Shares #Stockmarket #Stocks